PRESS RELEASE April 25, 2022 Jørgen Drejer, co-founder and board member, appointed interim Chairman of the Board of Directors; Thomas Feldthus, co-founder, appointed as CEO; Anita Milland
PRESS RELEASE March 29, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced a strategic program reprioritization and restructuring
PRESS RELEASE March 1, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming investor
PRESS RELEASE February 24, 2022 Three Months Ended December 31, 2021 (2020) Revenue was SEK 2.9 M (1.6 M)Operating loss was SEK -125.7 M (-68.6 M)Net loss was SEK -129.9 M (-44.4 M)Basic